FindTrial
Sign In

To study effect of Dhatri Pindi on Pittaj Abhishynada

Assessment of efficacy of Dhatri Pindi in Pittaj Abhishyanda:Randomised Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092944
Enrollment
72
Registered
2025-08-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H100- Mucopurulent conjunctivitis

Interventions

Intervention1: Nil: Nil

Sponsors

PMTs Ayurveda College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patients presenting with signs and symptoms of Pittaj Abhishyanda (Netra lalima, Kleda, Daah etc.). Patients willing to give informed & written consent. Irrespective of sex and Socioeconomics status.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from trachoma, dacrocystitis etc. 2. Patients with known case of HIV/Hbsag 3. Patients not willing for trial.

Design outcomes

Primary

MeasureTime frame
To evaluate efficacy of Dhatri Pindi Kalpna in Pittaj Abhishyanda.Timepoint: 7 day treatment with 4 follo up 0,3,5 and 7th day—

Secondary

MeasureTime frame
To review data related to Pittaj Abhishyanda and Pindi Kalpna in Ayurvedic texts. To review data related to Bacterial Conjunctivitis in Modern texts. To evaluate efficacy of Moxifloxacin eye drop in Pittaj Abhishyanda. To compare efficacy between Dhatri Pindi Kalpna and Moxifloxacin in Pittaj Abhishyanda. To observe any Adverse Drug Reaction.Timepoint: 7 day treatment with 4 follo up 0,3,5 and 7th day—

Countries

India

Contacts

Public ContactDr Swati Vishnu Sarwade

PMTs Ayurveda College,Shevgaon

drsarwadeswativ@gmail.com9422935125

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026